COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).

Lal, S; Hayward, CS; De Pasquale, C; Kaye, D; Javorsky, G; Bergin, P; Atherton, JJ; Ilton, MK; Weintraub, RG; Nair, P; Rudas, M; Dembo, L; Doughty, RN; Kumarasinghe, G; Juergens, C; Bannon, PG; Bart, NK; Chow, CK; Lattimore, J-D; Kritharides, L; Totaro, R; Macdonald, PS

COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).

Lal, S Hayward, CS De Pasquale, C Kaye, D Javorsky, G Bergin, P Atherton, JJ Ilton, MK Weintraub, RG Nair, P Rudas, M Dembo, L Doughty, RN Kumarasinghe, G Juergens, C Bannon, PG Bart, NK Chow, CK Lattimore, J-D Kritharides, L Totaro, R Macdonald, PS

Permalink

Publisher:: Elsevier BV
Publication Type:: Journal Article
Citation:: Heart, lung & circulation, 2020, 29, (7), pp. e94-e98
Issue Date:: 2020-05

Closed Access

	Filename	Description	Size
	1-s2.0-S1443950620301335-main.pdf	Published version	390.28 kB		View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Lal, S
dc.contributor.author	Hayward, CS
dc.contributor.author	De Pasquale, C
dc.contributor.author	Kaye, D
dc.contributor.author	Javorsky, G
dc.contributor.author	Bergin, P
dc.contributor.author	Atherton, JJ
dc.contributor.author	Ilton, MK
dc.contributor.author	Weintraub, RG
dc.contributor.author	Nair, P
dc.contributor.author	Rudas, M
dc.contributor.author	Dembo, L
dc.contributor.author	Doughty, RN
dc.contributor.author	Kumarasinghe, G
dc.contributor.author	Juergens, C
dc.contributor.author	Bannon, PG
dc.contributor.author	Bart, NK
dc.contributor.author	Chow, CK
dc.contributor.author	Lattimore, J-D
dc.contributor.author	Kritharides, L
dc.contributor.author	Totaro, R
dc.contributor.author	Macdonald, PS
dc.date.accessioned	2020-08-07T03:47:55Z
dc.date.available	2020-08-07T03:47:55Z
dc.date.issued	2020-05
dc.identifier.citation	Heart, lung & circulation, 2020, 29, (7), pp. e94-e98
dc.identifier.issn	1443-9506
dc.identifier.issn	1444-2892
dc.identifier.uri	http://hdl.handle.net/10453/142008
dc.description.abstract	Up to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier BV
dc.relation.ispartof	Heart, lung & circulation
dc.relation.isbasedon	10.1016/j.hlc.2020.04.005
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology, 1117 Public Health and Health Services
dc.subject.classification	Cardiovascular System & Hematology
dc.title	COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).
dc.type	Journal Article
utslib.citation.volume	29
utslib.location.activity	Australia
utslib.for	1102 Cardiorespiratory Medicine and Haematology
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2020-08-07T03:47:48Z
pubs.issue	7
pubs.publication-status	Published
pubs.volume	29
utslib.citation.issue	7

Abstract:

Up to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/142008